Inorganic Chemistry
Article
Solvents were dried prior to use. Tetrahydrofuran (THF) and toluene
were distilled from sodium/benzophenone and stored under Ar(g).
Dichloromethane (CH2Cl2) was distilled from CaH2. Hexane and
propan-2-ol for HPLC were of chromatographic grade and used without
further purification. Isopropyllithium (0.7 M in pentane), methyllithium
(1.6 M in Et2O), n-butyllithium (2.5 M in hexane), 1-bromo-hexadecane
(C16H33Br), 1,4-diazabicyclo[2.2.2]octane (DABCO), BH3·SMe2,
tributylphosphine, K2[PtCl4], [PdCl(η3-C3H5)]2, trimethylsilylacety-
lene (C5H10Si), phenylacetylene, and copper iodide (CuI) were
purchased from commercial source and used as received. (+) and
(−)-Ephedrine were purchased from commercial source and dried by
azeotropic shift of toluene on rotary evaporator. The toluene/HCl
solution was obtained by bubbling HCl gas, and the resulting solution
was titrated before use. 4,7-Bis(ethynyl)-2,1,3-benzothiadiazole was
prepared according to the literature.14 Reactions were monitored by
thin-layer chromatography (TLC) using 0.25-mm precoated silica gel
plates. Visualization was accomplished with UV light and/or appropriate
staining reagents. Flash chromatography was performed with the
indicated solvents using silica gel 60 (particle size 35−70 μm) or
aluminum oxide 90 standardized. The (2R,4S,5R)-(+)-3,4-dimethyl-2,5-
diphenyl-1,3,2-oxazaphospholidine-2-borane 2 and its enantiomer
(2S,4R,5S)-(−)-2 was prepared from appropriate (−)- or (+)-ephe-
drine, as previously described.11 The (Rp)-(+)-N-methyl-N-
[(1S,2R)(1-hydroxy-2-methyl-1-phenyl-2-propyl)]amino-i-propyl-phe-
nylphosphine borane 3 and (R)-(−)- and (S)-(+)-methylphenyl-i-
propylphosphine borane 4 were prepared from the (−)- or
(+)-ephedrine 1, respectively, according to the published procedure.11a
The complexes trans-dichloro-bis(tris-n-butylphosphine)platinum(II)
8,15 trans-bis(4-ethynylbenzene)bis(tris-n-butylphosphine) platinum-
(II) 9,16,17 and (+)-di-μ-chloro-bis{2[1-(dimethylamino)ethyl]phenyl-
C,N}dipalladium,18 and polymers poly(trans-(1,4-diethynylbenzene)-
bis(tris-n-butylphosphine)platinum(II)) 1119,20 and poly[trans-(bis-
4,7-ethynyl-2,1,3-benzothiadiazole)bis(tri-n-butylphosphine)platinum-
(II)] 14,21 were prepared according to reported procedures.
(R)-(−)-Heptadecylphenyl-i-propylphosphine Borane 5. This
compound is derived from (−)-ephedrine. In a two necked-flask
equipped with a magnetic stirrer and an argon inlet, a solution of 2.5 g of
(R)-(+)-methylphenyl-i-propylphosphine borane 4 (14.0 mmol) in
THF (10 mL) is added. The mixture is cooled to 0 °C, and 11.2 mL (2.5
M in hexane, 28.1 mmol) of n-butyllithium is slowly added with a syringe
while stirring. After the formation of a white precipitate, the mixture is
stirred for 1 h at 0 °C. 1-Bromo-hexadecane (4.43 g, 14.5 mmol) is
dissolved with a minimum of dry THF (5 mL) before use and added
slowly. The resulting mixture was progressively warmed to room
temperature and stirred for 2 h. After hydrolysis, the aqueous layer is
extracted twice with dichloromethane. The organic layers were dried
over anhydrous MgSO4, and the solvent was removed. The residue was
purified by column chromatography on silica gel using a mixture of
petroleum ether/CH2Cl2 8:2 as eluent. Yield 56%. White solid; mp ≤ 50
°C. [α]D25 = −3.2 (c = 1.0, CHCl3) for 96% ee. Rf = 0.51 (petroleum
ether/CH2Cl2, 8:2). 1H NMR (300 MHz, CDCl3): δ 7.53−7.47 (m, 2H,
CHarom), 7.32−7.23 (m, 3H, CHarom), 1.92 (m, 1H, CH, i-Pr), 1.67 (m,
2H, CH2), 1.48 (m, 2H, CH2), 1.03 (br s, 31H, CH3 and C17H35), 0.93
(dd, 3H, J = 14.4, 7.3 Hz, CH3, i-Pr), 0.80 (t, 3H, J = 6.2 Hz, CH3,
C17H35). 13C NMR (75 MHz, CDCl3): δ 132.51 (d, J = 8.0 Hz, CHarom),
131.1 (d, J = 2.3 Hz, CHarom), 128.6 (d, J = 9.2 Hz, CHarom), 127.5 (d, J =
49.7 Hz, Carom), 31.91 (s, CH2), 31.3 (d, J = 12.7 Hz, CH2), 29.6 (br d, J =
2.7 Hz, CH2), 29.5 (d, J = 3.6 Hz, CH2), 29.3 (d, J = 4.0 Hz, CH2), 29.0
(s, CH2), 25.1 (d, J = 35.5 Hz, CH), 23.0 (s, CH2), 22.8 (s, CH2), 22.7 (s,
CH2), 22.6 (s, CH2), 16.7 (s, CH3), 14.0 (s, CH3). 31P NMR (121 MHz,
CDCl3): δ +24.9 (d, J = 69.2 Hz). ESI-MS: m/z (%) = 427.4 (100) [M +
Na]+.
acetate 9:1 as eluent. After removal of the solvent under vacuum/argon,
the free phosphine was obtained in 98% yield. White solid. H NMR
1
(300 MHz, CDCl3): δ 7.44−7.38 (m, 2H, CHarom), 7.25−7.19 (m, 2H,
CHarom), 7.11 (m, 1H, CHarom), 2.84 (m, 6H, CH and CH2), 1.83−1.55
(m, 4H, CH2), 1.04 (br s, 26H, CH3 and C17H35), 0.90 (dd, 3H, J = 14.7,
7.8 Hz, CH3, i-Pr), 0.78 (t, 3H, J = 7.9 Hz, CH3, C17H35). 13C NMR (75
MHz, CDCl3): δ 137.6 (d, J = 16.2 Hz, Carom), 133.2 (d, J = 18.8 Hz,
CHarom), 128.6 (br.s, CHarom), 127.9 (d, J = 7.0 Hz, CHarom), 31.8 (s,
CH2), 31.3 (d, J = 19.6 Hz, CH2), 29.6 (br.s, CH2), 29.5 (d, J = 7.5 Hz,
CH2), 29.2 (d, J = 6.0 Hz, CH2), 27.1 (d, J = 8.3 Hz, CH), 26.1 (d, J =
14.3 Hz, CH2), 25.1 (d, J = 12.9 Hz, CH2), 22.6 (s, CH2), 19.5 (s, CH3),
19.3 (d, J = 2.3 Hz, CH3), 14.0 (s, CH3). 31P NMR (121 MHz, CDCl3): δ
−7.0. The enantiomeric excess of 6 (92% ee) was determined by
comparison with a racemic sample, by 31P NMR in the presence of
(+)-di-μ-chlorobis{2[1-(dimethylamino)ethyl]phenyl-C,N}-
dipalladium.18c 31P NMR(121 MHz, CDCl3): δ + 43.0 [(R)-
enantiomer].
(S)-Heptadecylphenyl-i-propylphosphine (S)-6. (Yield 98%.)
This enantiomer was prepared using a similar procedure as for (R)-6, but
starting from (S)-methylphenyl-i-propylphosphine borane 5. The
characterization data are identical to those for (R)-6. 31P NMR (121
MHz, CDCl3): δ +41.7 [(S)-enantiomer)].
Synthesis of the Complexes 7 [(S)-7 or (R)-7]. In a first flask, a
solution of HCl 4 M (100 mL) in distilled ethanol (200 mL) was
degassed with argon for 20 min, before use. In a second flask, equipped
with a magnetic stirrer, an argon inlet, and a condensor, 1.0 g of
phosphine 6 (2.5 mmol) and 0.40 g of K2[PtCl4] (1.3 mmol) were
introduced. The alcoholic HCl solution was then added using a cannula.
The mixture was heated under reflux for 4 h, cooled at −78 °C to afford a
yellow solid which was collected in the same temperature by filtration,
washed with ethanol, and dried under vacuum. The resulting residue was
filtered through a chromatography column on silica gel using hexane/
diethyl ether, 9:1. A yellow band was obtained first, containing trans-
{[(i-Pr)(C17H35)(Ph)P]2PtCl2} (7-trans); eluting further with diethyl
ether, an colorless band was collected, which was reduced to dryness to
provide cis-[((i-Pr)(C17H35)(Ph)P)2PtCl2] (7-cis). Yield 54% (ratio 7-
trans/7-cis, 6:4).
t r a n s - D i c h l o r o b i s [ ( R ) - h e p t a d e c y l p h e n y l - i -
propylphosphine]platinum(II) 7-trans. Yield 60%. Bright yellow
solid; mp = 213-215 °C. [α]D25 = −15.8 (c = 1.0, CHCl3) (derived from
1
(−)-ephedrine). Rf = 0.80 (hexane/diethyl ether, 9:1). H NMR (300
MHz, CDCl3): δ 7.65 (m, 4H, CHarom), 7.34 (m, 6H, CHarom), 2.76 (m,
2H, CH, i-Pr), 2.15 (m, 4H, CH2), 1.72 (m, 4H, CH2), 1.39 (m, 6H,
CH2), 1.18 (br.s, 62H, CH3 and C17H35), 0.81 (t, 6H, J = 6.0 Hz, CH3,
C17H35). 13C NMR (75 MHz, CDCl3): δ 133.6 (t, J = 4.0 Hz, CHarom),
130.1 (s, CHarom), 127.6 (t, J = 4.9 Hz, CHarom), 31.9 (s, CH2), 31.4 (t, J =
7.5 Hz, CH2), 30.9 (s, CH), 29.7 (br.s, CH2), 29.6 (s, CH2), 29.5 (s,
CH2), 29.3 (s, CH2), 29.2 (s, CH2), 24.5 (s, CH2), 22.7 (s, CH2), 22.0 (t,
J = 17.3 Hz, CH), 21.0 (t, J = 15.8 Hz, CH2), 18.3 (s, CH2), 17.4 (s,
CH3), 14.1 (s, CH3). 31P NMR (121 MHz, CDCl3): δ +20.0 (s, JPt−P
=
2502 Hz). ESI-MS: m/z (%) = 1068.6 (100) [M + Na]+. HRMS (ESI-
Q-TOF) Calcd for C52H94ClP2Pt [M − Cl]+: 1011.6168. Found:
1011.6181. Anal. Calcd for C52H94P2PtCl2 (1047.25): C 59.64, H 9.05.
Found: C 59.98, H 9.31.
cis-Dichlorobis[(R)-heptadecylphenyl-i-propylphosphine]-
25
platinum(II) 7-cis. Yield 40%. White solid; mp = 82−84 °C. [α]D
=
−5.7 (c = 1.0, CHCl3) (prepared from (R)-6). Rf = 0.10 (hexane/diethyl
ether, 9:1). H NMR (300 MHz, CDCl3): δ 7.23 (t, 2H, J = 8.0 Hz,
1
CHarom), 7.05 (t, 4H, J = 7.6 Hz, CHarom), 6.88 (t, 4H, J = 9 Hz, CHarom),
3.28 (m, 2H, CH, i-Pr), 2.17−1.63 (m, 8H, CH2), 1.47−1.14 (br.s, 62H,
CH3 and C17H35), 0.81 (t, 6H, J = 6.0 Hz, CH3, C17H35), 0.48 (dd, 6H, J
= 13.6, 6.2 Hz, CH3, i-Pr). 13C NMR (75 MHz, CDCl3): δ 131.4 (t, J =
4.0 Hz, CHarom), 130.4 (s, CHarom), 127.8 (t, J = 4.5 Hz, CHarom), 127.1
(d, J = 55.0 Hz, Carom), 31.9 (s, CH2), 31.4 (t, J = 8.3 Hz, CH2), 29.7 (br s,
CH2), 29.6 (s, CH2), 29.5 (s, CH2), 29.3 (s, CH2), 29.2 (s, CH2), 25.2 (s,
CH2), 22.7 (s, CH2), 19.9 (s, CH3), 16.3 (s, CH3), 14.1 (s, CH3). 31P
NMR (121 MHz, CDCl3): δ +9.7 (s, JPt−P = 3610 Hz). ESI-MS: m/z
(%) = 1068.6 (100) [M + Na]+. HRMS (ESI-Q-TOF) Calcd for
C52H94ClP2Pt [M − Cl]+: 1011.6168. Found: 1011.6189. Anal. Calcd
for C52H94P2PtCl2 (1047.25): C 59.64, H 9.05. Found: C 59.62, H 9.36.
(R)-Heptadecylphenyl-i-propylphosphine 6. This compound is
derived from (−)-ephedrine. In a 50 mL two-necked flask equipped with
a magnetic stirrer and an argon inlet, 0.40 g of phosphine borane 5 (1.0
mmol) and 0.56 g of DABCO (5.0 mmol) were dissolved in 10 mL of
toluene. The reaction mixture was heated at 50 °C for 12 h. After
cooling, the crude product was rapidly transferred via a cannula into a
column previously evacuated and filled with argon containing neutral
alumina. The reaction solution was filtered using degassed toluene/ethyl
B
dx.doi.org/10.1021/ic301829x | Inorg. Chem. XXXX, XXX, XXX−XXX